Evaluation of individuals with pulmonary nodules: When is it lung cancer?: Diagnosis and management of lung cancer: American College of Chest Physicians …

MK Gould, J Donington, WR Lynch, PJ Mazzone… - Chest, 2013 - Elsevier
Objectives The objective of this article is to update previous evidence-based
recommendations for evaluation and management of individuals with solid pulmonary …

[HTML][HTML] Imaging and cancer: a review

L Fass - Molecular oncology, 2008 - Elsevier
Multiple biomedical imaging techniques are used in all phases of cancer management.
Imaging forms an essential part of cancer clinical protocols and is able to furnish …

First human imaging studies with the EXPLORER total-body PET scanner

RD Badawi, H Shi, P Hu, S Chen, T Xu… - Journal of Nuclear …, 2019 - Soc Nuclear Med
Within the EXPLORER Consortium, the construction of the world's first total-body PET/CT
scanner has recently been completed. The 194-cm axial field of view of the EXPLORER …

Appropriate use criteria for somatostatin receptor PET imaging in neuroendocrine tumors

TA Hope, EK Bergsland, MF Bozkurt… - Journal of Nuclear …, 2018 - Soc Nuclear Med
Somatostatin receptor (SSTR) PET has demonstrated a significant improvement over
conventional imaging (CI) in patients with neuroendocrine tumors (NETs). SSTR PET should …

A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies

AGS Oldroyd, AB Allard, JP Callen, H Chinoy… - …, 2021 - academic.oup.com
Objectives To identify clinical factors associated with cancer risk in the idiopathic
inflammatory myopathies (IIMs) and to systematically review the existing evidence related to …

Whole-Body PET/CT Scanning: Estimation of Radiation Dose and Cancer Risk1

B Huang, MWM Law, PL Khong - Radiology, 2009 - pubs.rsna.org
Purpose: To estimate the radiation dose from whole-body fluorine 18 (18F)-
fluorodeoxyglucose (FDG) positron emission tomographic (PET)/computed tomographic …

[HTML][HTML] Clinical application of radiolabeled RGD peptides for PET imaging of integrin αvβ3

H Chen, G Niu, H Wu, X Chen - Theranostics, 2016 - ncbi.nlm.nih.gov
Molecular imaging for non-invasive assessment of angiogenesisis is of great interest for
clinicians because of the wide-spread application of anti-angiogenic cancer therapeutics …

PET/MRI: paving the way for the next generation of clinical multimodality imaging applications

BJ Pichler, A Kolb, T Nägele… - Journal of Nuclear …, 2010 - Soc Nuclear Med
Multimodality imaging and, more specifically, the combination of PET and CT has matured
into an important diagnostic tool. During the same period, concepts for PET scanners …

[PDF][PDF] SNMMI procedure standard/EANM practice guideline for SSTR PET: imaging neuroendocrine tumors

TA Hope, M Allen-Auerbach, L Bodei… - Journal of Nuclear …, 2023 - Soc Nuclear Med
Somatostatin receptor (SSTR) imaging using PET has replaced scintigraphic imaging using
111In-pentetreotide (OctreoScan), unless PET is unavailable. Several benefits of SSTR PET …

[HTML][HTML] Progress and future trends in PET/CT and PET/MRI molecular imaging approaches for breast cancer

Y Ming, N Wu, T Qian, X Li, DQ Wan, C Li, Y Li… - Frontiers in …, 2020 - frontiersin.org
Breast cancer is a major disease with high morbidity and mortality in women worldwide.
Increased use of imaging biomarkers has been shown to add more information with clinical …